Sen. Ron Wyden (D-OR) (Francis Chung/E&E News/Politico via AP Images)
Senate Finance Chair Wyden continues fight over low pharma tax rates, this time with BMS
Sen. Ron Wyden (D-OR) isn’t done digging into the particularly low tax rates for pharma companies, and how their foreign ops can lower those bills …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
